← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 1986Last known activity
Mar 1, 2026
Timeline
1940s
- Jan 1, 1949
National Institute of Mental Health (NIMH)— Founded
Drugs by trial phase (272 distinct, 651 trials)
Phase 4 (114 own, 0 via acquisition)
Phase 3 (17 own, 0 via acquisition)
Phase 2 (73 own, 0 via acquisition)
Phase 1 (46 own, 0 via acquisition)
Other trials (22 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Acquired Immunodeficiency Syndrome
- Aggression
- Agoraphobia
- Alcoholism
- Alzheimer Disease
- Anhedonia
- Anorexia
- Anorexia Nervosa
- Anxiety Disorders
- Anxiety, Separation
- Asperger Syndrome
- Asphyxia Neonatorum
- Atherosclerosis
- Attention Deficit and Disruptive Behavior Disorders
- Attention Deficit Disorder with Hyperactivity
- Autism Spectrum Disorder
- Autistic Disorder
- Autoimmune Diseases
- Behavioral Symptoms
- Binge-Eating Disorder
- Bipolar Disorder
- Body Dysmorphic Disorders
- Bone Diseases, Metabolic
- Borderline Personality Disorder
- Bulimia
- Bulimia Nervosa
- Cardiovascular Diseases
- Carotid Artery Diseases
- Central Nervous System Diseases
- Child Development Disorders, Pervasive
- Chorioamnionitis
- Chromosome Deletion
- Chromosome Disorders
- Cognition Disorders
- Cognitive Dysfunction
- Communicable Diseases
- Compulsive Personality Disorder
- Conduct Disorder
- Coronary Artery Disease
- Coronary Disease
- Cysticercosis
- Delusions
- Dementia
- Dementia, Vascular
- Depression
- Depression, Postpartum
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Developmental Disabilities
- Diabetes Mellitus
- Disease
- Disruptive, Impulse Control, and Conduct Disorders
- Dyskinesia, Drug-Induced
- Dyskinesias
- Dysthymic Disorder
- Epilepsy
- Fatigue
- Feeding and Eating Disorders
- Fragile X Syndrome
- Frailty
- Gambling
- Gaucher Disease
- Head and Neck Neoplasms
- Heart Diseases
- Heart Failure
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Herpes Genitalis
- HIV Infections
- HIV Seropositivity
- Hot Flashes
- Hyperkinesis
- Hypochondriasis
- Infections
- Inflammation
- Insulin Resistance
- Major Depressive Disorder
- Malnutrition
- Memory Disorders
- Mental Disorders
- Metabolic Syndrome
- Mood Disorders
- Movement Disorders
- Musculoskeletal Pain
- Myocardial Ischemia
- Myositis
- Nervous System Diseases
- Neurocognitive Disorders
- Neurocysticercosis
- Neurodegenerative Diseases
- Neurodevelopmental Disorders
- Obsessive-Compulsive Disorder
- Osteoporosis
- Panic Disorder
- Parkinson Disease
- Personality Disorders
- Phobia, Social
Recent trials (50)
- NCT06977308CollaboratorPhase 1Mar 1, 2026
- NCT07124559CollaboratorPhase 1/Phase 2Dec 15, 2025
- NCT07169630Lead sponsorPhase 1Dec 2, 2025
- NCT07027839Lead sponsorPhase 1Dec 2, 2025
- NCT07027839OfficialPhase 1Dec 2, 2025
- NCT07169630OfficialPhase 1Dec 2, 2025
- NCT07231497CollaboratorPhase 3Dec 1, 2025
- NCT07263022CollaboratorPhase 3Dec 1, 2025
- NCT07226895CollaboratorPhase 1/Phase 2Nov 30, 2025
- NCT07040319CollaboratorPhase 1/Phase 2Nov 28, 2025
- NCT07278505CollaboratorPhase 1/Phase 2Oct 28, 2025
- NCT07123467CollaboratorPhase 3Oct 1, 2025
- NCT07003997CollaboratorPhase 2Sep 3, 2025
- NCT07022405CollaboratorPhase 2Aug 31, 2025
- NCT07110831CollaboratorPhase 4Aug 14, 2025
Details
- Founded
- Bethesda, MD, US Jan 1, 1949
- Last known activity
- Mar 1, 2026